Latency: A Biomarker Discovery Pipeline
Amalio Telenti of the Institute of Microbiology in Switzerland proposes to identify biomarkers specific to HIV latency using high-throughput screening of RNA sequences and a customized screening tool for validating HIV positive individuals. If successful, the biomarkers could be used in the study of HIV latency reservoirs and aid eradication efforts.